Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Exagen Inc.

Exagen Inc. (XGN) Stock Overview

Explore Exagen Inc.’s financial performance, market position, analyst ratings, and future outlook.

XGN●NASDAQ
HealthcareMedical - Diagnostics & Research
$6.65
$0.20(3.10%)
U.S. Market opens in 13h 57m

Exagen Inc. (XGN)

Meyka AI Score

Z

Key Financials

Market Cap160.7M
P/E Ratio-7.88
EPS (TTM)$-0.69
ROE-1.22%
Fundamental Analysis

AI Price Forecasts

1 Month$6.05
3 Months$4.83
1 Year Target$6.29

XGN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Exagen Inc. (NASDAQ: XGN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Exagen Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of XGN on the NASDAQ shows an RSI of 73.86, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $6.29 for the NASDAQ listing.

Key metrics behind Exagen Inc.'s NASDAQ-traded stock include a P/E ratio of -7.88 and a market capitalization of 160.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of XGN on the NASDAQ.

Price Performance (NASDAQ: XGN)

1-Day Change
3.10%
5-Day Change
43.94%
1-Month Change
51.14%
3-Month Change
115.21%
6-Month Change
97.92%
Year-to-Date (YTD) Change
9.38%
1-Year Change
-25.03%
3-Year Change
143.59%
5-Year Change
-36.67%
All-Time (Max) Change
-64.21%

Contact Information

https://www.exagen.com
760 560 1501
1261 Liberty Way, Vista, CA, 92081

Company Facts

2,160 Employees
IPO DateSep 19, 2019
CountryUS
Actively Trading

Frequently Asked Questions